Aim: We performed a meta-analysis of randomized controlled trials (RCT) and observational studies to answer the two following questions: (i) whether low maternal circulating 25 hydroxyvitamin D (25-OHD) is associated with an increased risk of preterm birth (PTB) or spontaneous PTB (sPTB); and (ii) whether vitamin D supplementation alone during pregnancy can reduce the risk of PTB. Methods: Literature search was carried out using Pubmed, Web of Science and Embase databases up to June 2016. Pooled OR or relative risk (RR) with 95%CI were computed using fixed or random effects models depending on the size of heterogeneity. Subgroup analysis was used to explore potential sources of between-study heterogeneity. Publication bias was evaluated using Egger's test and Begg's test. Results: Twenty-four articles (six RCT and 18 observational studies) were identified. Maternal circulating 25-OHD deficiency (pooled OR, 1.25; 95%CI: 1.13-1.38) rather than insufficiency (pooled OR, 1.09; 95%CI: 0.89-1.35) was associated with an increased risk of PTB, and vitamin D supplementation alone during pregnancy could reduce the risk of PTB (pooled RR, 0.57; 95%CI: 0.36-0.91). This was also the case for the sPTB subgroup (circulating 25-OHD <50 vs >50 nmol/L; pooled OR, 1.45; 95%CI: 1.20-1.75). Conclusions: Maternal circulating 25-OHD deficiency could increase PTB risk and vitamin D supplementation alone during pregnancy could reduce PTB risk. Extrapolation of the results, however, must be done with caution, and there is urgent need for larger, better-designed RCT to confirm this effect.
Introduction
Preterm birth (PTB) is the leading cause of neonatal morbidity and mortality, with an estimated prevalence of 11.1% at the global level, and it continues to be a major public health concern. 1 In addition to higher rates of neonatal morbidity, preterm infants are exposed to a higher risk of respiratory distress syndrome. 2 The annual societal economic costs associated with PTB are enormous. A large number of independent causes can contribute to PTB, such as intrauterine infection, low prepregnancy body mass index (BMI), and multiple gestation, [3] [4] [5] but the etiology of PTB is still not fully understood, and there remain many risk factors still to be identified.
Vitamin D deficiency in reproductive-age women is common. 6 In one cohort in the Netherlands, 53.2% had circulating 25 hydroxyvitamin D 25-OHD concentration < 50 nmol/L, and 26.1% had concentration <25 nmol/L; 7 and in a recent multiethnic cohort study in Norway, 45% of South Asian, 40% of Middle Eastern and 26% of Sub-Saharan African pregnant women had circulating 25-OHD <25 nmol/L. 8 In a survey of Asian subjects, 77.3% had circulating 25-OHD concentration < 50 nmol/L, and 28.6% had concentration <25 nmol/L. 9 Lower maternal vitamin D status during pregnancy is a risk factor for various adverse birth outcomes including PTB. 10 Epidemiologic studies and randomized trials concerning the association of maternal hypovitaminosis D during pregnancy and PTB yielded mixed results. A case-cohort study published in 2015 found that the risk of PTB was higher for vitamin D deficiency or insufficiency compared with sufficiency. 11 Most observational studies, however, did not show a significant relationship. 9, [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] A trial of vitamin D supplementation suggested that 25-OHD serum concentration > 100 nmol/L (vs <50 nmol/L) could significantly reduce the risk of PTB. 25 Other studies, however, did not obtain the same results. A recent meta-analysis of 24 observational studies found that low vitamin D (<50 nmol/L) increased the risk of PTB (OR, 1.58; 95%CI: 1.08-2.31). 26 Another recent meta-analysis combining 10 observational studies also confirmed this view and suggested more high-quality randomized controlled trials (RCT) are needed. 27 Both of these meta-analyses, however, included only observational studies and could not provide a causal effect, and should not be used as a basis for population-wide vitamin D supplementation during pregnancy. In addition, they could not distinguish between the types of PTB, which have very different mechanisms. Furthermore, many observational studies and RCT were published after these two meta-analyses. Therefore, we carried out an up-date meta-analysis by combining all available data for both observational studies and RCT to obtain a more precise estimation and evaluate the effect of vitamin D on the risk of PTB and spontaneous PTB (sPTB).
Methods

Search Strategy
The aim of the search was to identify studies on the association between maternal vitamin D status and supplementation and PTB, or that had relevant extractable data. Two investigators (S-S.Z., Y-H.T.) searched Pubmed, Web of Science and Embase databases up to June 2016. The search included terms for exposure
and outcome ('premature birth' [Mesh] OR 'preterm birth' OR 'premature newborn' OR 'preterm labor' OR 'very premature birth') to identify eligible articles. In addition, references in the articles identified were also searched to locate additional references not identified by the initial search that might be useful. Original articles published in English were included, and case reports, editorials, reviews, letters and comments were excluded.
Inclusion Criteria
For initial screening, the record titles and abstracts were used. Further screening involved reading full-text publications and supplementary information from studies that initially satisfied the inclusion criteria. The following criteria were used: (i) observational studies (e.g. cohort, case-control or cross-sectional studies) and RCT; (ii) investigation of maternal serum 25-OHD or oral supplementation with vitamin D alone during pregnancy (for RCT, controls of interest were: no supplementation/placebo, or routine care [ferrous sulfate and calcium, but no vitamin D]); (iii) PTB as the diagnosed outcome; (iv) provision of sufficient data to calculate an effect size for the association between pregnancy 25-OHD status/supplementation and PTB; and (v) subjects consisting of pregnant women without HIV infection. PTB was defined as delivery of a liveborn neonate before 37 weeks of gestation. sPTB was defined as PTB at <37 weeks' gestation after preterm labor with intact membranes or preterm pre-labor rupture of the fetal membranes.
Data Extraction and Quality Assessment
Two reviewers independently extracted relevant data from each full-text article and recorded the data directly onto previously designed data extraction spreadsheets. Any discrepancies were resolved by consensus or discussion with another investigator not in the first 2 groups, if needed. The following key information was collected: study design, first author's last name, year of publication, location, ethnicity, gestational age at serum sampling, assay method, proportion of vitamin D deficiency, quality score/bias risk, and intervention and control scheme. Observational study quality was determined using a nine-stars system based on the Newcastle-Ottawa Scale 28 from three perspectives: subject group selection, comparability of the groups, and the ascertainment of either the exposure or outcome of interest for case-control or cohort studies, respectively. The Cochrane Collaboration tool for assessing risk of bias in RCT 29 was used. The following items were evaluated: generation of the allocation sequence (selection bias); concealment of the allocation sequence (selection bias); blinding (detection and performance bias); blinding of participants and personnel to outcome S-S. Zhou et al.
assessment; incomplete outcome data (attrition bias); selective outcome reporting (reporting bias); and other biases.
Statistical Analysis
We extracted the data from all selected papers to construct 2 × 2 tables. The relationship between 25-OHD and PTB was reported in different ways, including as proportions, OR and relative risk (RR; 95%CI). There was also no consensus on the 25-OHD concentration definitions (deficiency, insufficiency, and sufficiency). When 25-OHD concentration was reported in ng/mL, we transformed this to nmol/L. For trials testing multiple intervention arms (of daily or bolus doses), we pooled data from intervention arms.
We visually assessed the pooled OR/RR and 95%CI on forest plot. The extent of between-study heterogeneity was assessed using I 2 statistics. I 2 = 25%, 50%, and 75% corresponded to low, moderate, and high degrees of heterogeneity, respectively. Potential publication bias was assessed using Egger's test and Begg's test. Subgroup analysis of observational studies was further performed according to PTB type, design type, latitude (low latitude, 30°N-30°S; mid-latitude, 30°N/S-60°N/S; high latitude, >60°N/S) and ethnicity (White, Black, Asian and mixed race). Subgroup analysis of RCT was performed according to sample size, risk bias and dosage regimen. We did not conduct subgroup analysis of BMI, season or diet due to insufficient data. Sensitivity analysis was calculated to explore the extent to which inferences might be affected by a particular study. All statistical analyses were processed with Stata 9.0. P < 0.05 (two-sided) was considered statistically significant.
Results
Literature Search
The literature search identified 537 relevant articles, with no additional articles found during the reference list search. After the initial title and abstract screening, 56 studies remained. We carried out full-text review of 56 studies. Among these, 32 studies were excluded because they did not focus on associations between 25-OHD concentration and PTB (n = 21), had no extractable data (n = 4), had participants with HIV infection (n = 1), compared different doses of vitamin D without a placebo or control group (n = 3); and included oral vitamin D + calcium supplements: (n = 3). Finally, 24 articles, consisting of six RCT and 18 observational studies, were identified via the strict screening process. (Fig. S1 ). The Newcastle-Ottawa Scale quality scores ranged from 8 to 10, indicating high quality (Table S1 ). The score for one article, however, was unable to be evaluated because the full text was not available, and three RCT had low risk of bias. Table 1 lists the characteristics of the 18 observational studies 9, [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [30] [31] [32] and six RCT. [33] [34] [35] [36] [37] [38] There was some disparity in the definition of PTB between studies. Most studies defined PTB as delivery before 37 weeks' gestation, but two studies used a threshold of <35 weeks. 18, 21 All studies measured maternal serum 25OH-D at some point during pregnancy or at delivery. Vitamin D dosage administered to the intervention group(s) ranged from a daily dosage of 400 IU to multiple bolus dosage of 120 000 IU. The risk (i.e. OR) for PTB among women receiving supplement ranged from 0.06 to 1.20, and positive and significant results were reported in one out of the six RCT. 34 All of the interventions consisted of supplement of oral vitamin D alone, and the comparison was placebo or routine care (ferrous sulfate 200 mg and calcium 600 mg daily, but no vitamin D). Of the six RCT, three had a low risk of bias, one had a moderate risk of bias, and two had a high risk of bias.
Study Characteristics
Quantitative Synthesis
The results of meta-analysis in observational studies appear to be inconsistent due to the different cut-off points. Lower 25-OHD concentration (<50 vs >50 nmol/L; pooled OR, 1.25; 95%CI: 1.13-1.38) during pregnancy was associated with an increased risk of PTB (Fig. 1) . This relationship, however, was not statistically significant when the 25-OHD cut-offs <75 vs >75 nmol/L were used (pooled OR, 1.09; 95%CI: 0.89-1.35; Fig. 2 ). In addition, the RR of six trials involving 1687 women was 0.57 (95%CI: 0.36-0.91), and test of heterogeneity, I 2 = 26.2% (P = 0.238; Fig. 3 ), indicating a trend that women who received vitamin D supplements had a lower PTB risk.
Subgroup Analysis
Subgroup analysis was carried out to identify underlying sources of heterogeneity among these studies. In the subgroup analysis of PTB type, vitamin D deficiency was significantly associated with risk of sPTB (pooled OR, 1.45; 95%CI: 1.20-1.75; test of heterogeneity, I 2 = 0.0%; P = 0.976; Fig. 4 ). With respect to subgroup analysis of observational study type, latitude and ethnicity, we found a statistically significant Vitamin D and preterm birth Vitamin D and preterm birth association in subgroup of retrospective studies, midlatitude and mixed race ( Figs S2-4 ). In addition, in the analysis of RCT, the studies with sample size >100, low risk of bias and single-dose supplementation of vitamin D, showed that vitamin D was significantly associated with PTB ( Figs S5-7) .
Sensitivity Analysis
When each study was excluded from the metaanalysis in turn, the pooled OR in observational studies did not change fundamentally, indicating that the results could not be solely attributed to the effect of a single study. In the leave-one-out sensitivity analysis of RCT, however, the pooled RR were materially altered when the Sablok et al. and Grant et al. studies were excluded.
34,37
Publication Bias
No publication bias was detected in the observational studies (P = 0.89, Begg's test; P = 0.72, Egger's test) or in the RCT (P = 0.45, Begg's test; P = 0.44, Egger's test).
Discussion
We systematically reviewed 18 observational studies and six RCT on the relationship between 25-OHD concentration and vitamin D supplementation and PTB incidence. We found that results differed according to the cut-offs used: serum 25-OHD >50 nmol/L (vs <50 nmol/L) was associated with a lower Vitamin D and preterm birth likelihood of PTB, but this inverse association was not seen for the cut-off 75 nmol/L. The protective effect of vitamin D was less obvious for 25-OHD >75 nmol/L. In addition, the protective effect of vitamin D was also confirmed for sPTB using the cut-off 50 nmol/L. And when stratified according to study design, this inverse association was seen in the retrospective studies, but was not supported by the prospective studies. A possible explanation for this inconsistency is that many confounding factors such as location, ethnicity, gestational age at serum sampling and assay method were not fully adjusted in many retrospective studies. And because of the inherent shortage of retrospective studies, they are less effective in causal inference compared with prospective studies. Furthermore, the association of serum 25-OHD >50 nmol/L (vs <50 nmol/L) with lower likelihood of PTB was observed for mid-latitude. A possible explanation is that lower prevalence of vitamin D deficiency in the low-latitude countries limited the ability to assess this association. We also noted the inverse association for mixed-race ethnicity. This may be because mixed-race studies included Black ethnicity, and the higher prevalence of vitamin D deficiency among Black subjects might lead to this result. We could not exclude the possibility, however, that positive results might be due to the larger sample size in the mid-latitude and mixed-race studies. We did not conduct subgroup analysis for BMI, season and diet due to insufficient data, but a previous study has shown that confounding by fish intake and physical activity has little effect on vitamin D-preterm effect estimates. 39 On sensitivity analysis of the observational studies, the results could not be solely affected by any single study, indicating that the present results are stable and reliable.
Data from six trials involving 1687 women suggested that individuals who received vitamin D supplements during pregnancy had a lower risk of PTB compared with women receiving placebo or routine antenatal care. It is important to note that we excluded trials that combined vitamin D and calcium supplementation: in their meta-analysis, De-Regil et al. found that women who received vitamin D and calcium supplements together had an increased risk of PTB (RR, 1.57; 95%CI: 1.02-2.43). 40 Furthermore, studies with sample size >100, low risk of bias, and single-dose vitamin D supplementation all showed that vitamin D supplement could reduce the risk of PTB, but we could not draw a conclusion because the subgroups had only one or two RCTs, and the results may be misleading. Sensitivity analysis of RCT indicated that the Sablok et al. 34 and Grant et al. studies 37 could both significantly affect the results. A possible reason is that the small sample size generated less stable results, therefore it is difficult to exclude the possibility that the positive association is due to chance.
The mechanism underlying the possible protective effect of vitamin D on PTB risk might be complicated due to the great variety of immunomodulator effects of 25-OHD. We speculated that vitamin D might protect against PTB by reducing infection and inflammation, 41 given that the major cause of PTB is inflammation and intrauterine infection. 42 Also, maternal serum 25-OHD and 1,25-diOHD could inhibit inflammatory factors, such as tumor necrosis factor-α 43 and interleukin 6, 44 while at the same time promote the generation of anti-inflammatory cytokine and cathelicidin, respond to microbial invasion through activation of toll-like receptor on monocytes and macrophages. 45 In addition to its anti-inflammatory effects, vitamin D might also reduce iatrogenic PTB by influencing placental function, given that 1,25-dihydroxyvitamin D3 can reduce oxidative stress, 46 which is associated with preeclampsia and then iatrogenic PTB.
This study has several strengths. The present metaanalysis comprehensively reviewed both observational studies and RCT, which provides a much wider view of this important issue. Also this study included a large number of participants, allowing a much greater possibility of obtaining reliable conclusions. Furthermore, when the results of observational studies were combined, we considered two different cut-off points separately, which could lead to new insights on this issue. Several limitations of the study should also be acknowledged. On the one hand, the interpretation and comparison of observational studies were limited by the varying characteristics of these studies, such as 25-OHD measurement timing, definition of PTB, assay technique and the study design (e.g. prospective cohort, case-control, or cross-sectional). On the other hand, for intervention studies, inconsistent dosage regimen, timing of initiation and quality of design, limited the efficacy of generalization.
In conclusion, maternal circulating 25-OHD deficiency (<50 vs >50 nmol/L) rather than insufficiency (<75 vs >75 nmol/L) was associated with increased risk of PTB, and maternal oral supplementation with vitamin D alone during pregnancy can reduce the risk of PTB. Extrapolation of the present results, however, needs to be cautious, and well-designed RCT are urgently warranted to confirm these results.
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